RGS2 and breast cancer: These findings demonstrate that the anti-tumor activity and the inhibition of calcium influx by PCI-24781 are impaired in RGS2-depleted cells, indicating that RGS2 may be a potential biomarker of PCI-24781 in breast cancer cells.